Jefferies Financial Group’s BeOne Medicines Ltd ONC Stock Holding History

Jefferies Financial Group’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.82M	Buy	6,400 +200	+3%	+$58.9K	0.01%	726
2026 Q1	$1.84M	Hold	6,200	–	–	0.01%	671
2025 Q4	$1.88M	Buy	+6,200	New	+$2.03M	0.01%	839
2025 Q3	–	Sell	-2,900	Closed	-$702K	–	1740
2025 Q2	$702K	Hold	2,900	–	–	0.01%	818
2025 Q1	$789K	Buy	2,900 +900	+45%	+$210K	0.01%	896
2024 Q4	$369K	Buy	+2,000	New	+$409K	﹤0.01%	1197
2024 Q2	–	Sell	-8,043	Closed	-$1.26M	–	1945
2024 Q1	$1.26M	Sell	8,043 -37,957	-83%	-$6.11M	0.01%	739
2023 Q4	$8.3M	Hold	46,000	–	–	0.05%	268
2023 Q3	$8.27M	Buy	+46,000	New	+$9.1M	0.07%	208

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jefferies Financial Group's ONC Position: Q2 2026 in Review

Jefferies Financial Group increased its BeOne Medicines Ltd (ONC) stake by 3.2% in Q2 2026, buying an estimated $58.9K and bringing the position to 6,400 shares worth $1.82M. The position accounts for 0.01% of the portfolio, ranked #726.

Jefferies Financial Group first reported a position in ONC in Q3 2023 and has held it in 9 quarters since. The position peaked at $8.3M in Q4 2023. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Jefferies Financial Group held 6,400 shares of BeOne Medicines Ltd worth $1.82M as of Q2 2026.
Jefferies Financial Group bought 200 BeOne Medicines Ltd shares in Q2 2026, an estimated $58.9K.
BeOne Medicines Ltd made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #726 holding.
Jefferies Financial Group first reported a position in BeOne Medicines Ltd in Q3 2023 and has held it in 9 quarters since.
Jefferies Financial Group's BeOne Medicines Ltd position peaked at $8.3M in Q4 2023.
283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.